Dexamethasone enhancement of hyperoxic lung inflammation in rats independent of adhesion molecule expression

Biochemical Pharmacology

Volumn 56, Issue 2, 1998, Pages 259-268

  Ramsay, Patricia L ^a   Smith, Charles V ^a   Geske, Robert S ^a   Montgomery, Charles A ^a   Welty, Stephen E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adhesion molecule; Animal model; Lung inflammation; Lung injury; Oxygen toxicity

Indexed keywords

DEXAMETHASONE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HYPEROXIA; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG FLUID; LUNG INJURY; MALE; NEUTROPHIL; NONHUMAN; OXYGEN TOXICITY; PRIORITY JOURNAL; RAT;

ANIMALS; DEXAMETHASONE; E-SELECTIN; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LUNG; MALE; OXYGEN INHALATION THERAPY; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031726450     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(98)00138-5     Document Type: Article

References (41)

1. Bonikos DS and Bensch KG, Pathogenesis of BPD. In: Bronchopulmonary Dysplasia (Eds. Merritt TA, Northway WH Jr and Boynton BR), pp. 33-58. Blackwell Scientific Publications, Palo Alto, CA 1988.
2. Northway WH Jr, Rosan RC and Porter DY, Pulmonary disease following respiratory therapy of hyaline membrane disease. N Engl J Med 276: 357-368, 1967.
3. Yam J, Frank L and Roberts RJ, Age-related development of pulmonary antioxidant enzymes in the rat. Proc Soc Exp Biol Med 157: 293-296, 1973.
4. 2-rich environment: The antioxidant enzymes in the developing rabbit lung. Pediatr Res 18: 240-244, 1984.
5. Tanswell AK and Freeman BA, Pulmonary antioxidant enzyme maturation in the fetal and neonatal rat. I. Developmental profiles. Pediatr Res 18: 584-587, 1984.
6. Mammel MC, Green TP, Johnson DE and Thompson TR, Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1: 1356-1358, 1983.
7. Avery GB, Fletcher AB, Kaplan M and Brudno DS: Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75: 106-111, 1985.
8. Cummings JJ, D'Eugenio DB and Gross SJ, A controlled trial of dexamethasone in pre-term infants at risk for bronchopulmonary dysplasia. N Engl J Med 320: 1505-1510, 1989.
9. 2 exposure. Pediatr Res 32: 215-221, 1992.
10. Yam J and Roberts RJ, Pharmacological alteration of oxygen-induced lung toxicity. Toxicol Appl Pharmacol 47: 367-375, 1979.
11. Koizumi M, Frank L and Massaro D, Oxygen toxicity in rats: Varied effect of dexamethasone treatment depending on duration of hyperoxia. Am Rev Respir Dis 131: 907-911, 1985.
12. Town GI, Phillips GJ, Louden J, Holgate ST and Kelly FJ, Dexamethasone treatment fails to reduce oxygen-induced lung injury in the preterm guinea pig. Biochem Pharmacol 46: 1565-1572, 1993.
13. Smith, LJ, Hyperoxic lung injury: Biochemical, cellular, and morphological characterization in the mouse. J Lab Clin Med 106: 269-278, 1985.
14. Crapo JD, Morphologic changes in pulmonary oxygen toxicity. Annu Rev Physiol 48: 721-731, 1986.
15. Bressack MA, McMillan DD and Bland RD, Pulmonary oxygen toxicity: Increased microvascular permeability to protein in anesthetized lambs. Lymphology 12: 133-139, 1979.
16. Hansen TN, Hazinski TA and Bland RD, Vitamin E does not prevent oxygen-induced lung injury in newborn lambs. Pediatr Res 16: 583-587, 1982.
17. Shasby DM, Fox RB, Harada RN and Repine JE, Reduction of the edema of acute hyperoxic lung injury by granulocyte depletion. J Appl Physiol 52: 1237-1244, 1982.
18. Raj JU, Hazinski TA and Bland RD, Oxygen-induced lung microvascular injury in neutropenic rabbits and lambs. J Appl Physiol 58: 921-927, 1985.
19. Bevilacqua MP and Nelson RM, Selectins. J Clin Invest 91: 379-387, 1993.
20. Horgan MJ, Ge M, Gu J, Rothlein R and Malik AB, Role of ICAM-1 in neutrophil-mediated lung vascular injury after occlusion and reperfusion. Am J Physiol 261: H1578-H1584, 1991.
21. Welty SE, Rivera JL, Elliston J, Smith CV, Zeb T, Ballantyne CM, Montgomery CA and Hansen TN, Increases in lung tissue expression of intercellular adhesion molecule-1 are associated with hyperoxic lung injury and inflammation in mice. Am J Respir Cell Mol Biol 9: 393-400, 1993.
22. Ramsay PL, Geske RS, Montgomery CA and Welty SE, Increased soluble E-Selectin is associated with lung inflammation and injury in hyperoxia-exposed rats. Toxicol Lett 87: 157-165, 1996.
23. Zeb T, Peidboeuf B, Gamache M and Welty SE, P-Selectin is upregulated early in the course of hyperoxic lung injury in mice. Free Radio Biol Med 21: 567-574, 1996.
24. Keeney SE, Noworyta K and Schmalstieg FC, The effect of hyperoxia on pulmonary E-Selectin and ICAM-1 in neonatal rats. Pediatr Res 37: 337A, 1995.
25. Wegner CD, Wolyniec WW, LaPlante AM, Marschman K, Lubbe K, Haynes N, Rothlein R and Letts GL, Intercellular adhesion molecule-1 contributes to pulmonary oxygen toxicity in mice: Role of leukocytes revisited. Lung 170: 267-279, 1992.
26. Ramsay PL, Welty SE, Bree MP and Hansen TN, Lung injury and inflammation are reduced in hyperoxic mice by inhibition of neutrophil β2 integrin CD11a/CD18. Pediatr Res 35: 396A, 1994.
27. Welty SE and Pena J, Mice deficient in ICAM-1 expression and with reduced CD18 expression have increases in hyperoxic lung inflammation and injury. Pediatr Res 39: 392A, 1996.
28. Erdmann AJ, Vaughan TR III, Brigham KL, Woolverton WC and Staub NC, Effect of increased vascular pressure on lung fluid balance in unanesthetized sheep. Circ Res 37: 271-284, 1975.
29. Pearce ML, Yamashita J and Beazell J, Measurement of pulmonary edema. Circ Res 16: 482-488, 1965.
30. Goldblum SE, Kuei-Meng W and Jay M, Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J Appl Physiol 59: 1978-1985, 1985.
31. Bradford MM, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 48-54, 1976.
32. Pinkus GS and Pinkus JL, Myeloperoxidase: A specific marker for myeloid cells in paraffin sections. Mod Pathol 4: 733-741, 1991.
33. Christensen RD and Rothstein G, Neutrophil myeloperoxidase concentration: Changes with development and during bacterial infection. Pediatr Res 19: 1278-1282, 1985.
34. Pember SO and Kinkade JM Jr, Differences in myeloperoxidase activity from neutrophilic polymorphonuclear leukocytes of differing density: Relationship to selective exocytosis of distinct forms of the enzyme. Blood 61: 1116-1124, 1983.
35. Wilson JW, Treatment or prevention of pulmonary cellular damage with pharmacologic doses of corticosteroid. Surg Gynecol Obstet 134: 675-681, 1972.
36. Stenmark KR, Eyzaguirre M, Westcott JY, Henson PM and Murphy RC, Potential role of eicosanoids and PAF in the pathophysiology of bronchopulmonary dysplasia. Am Rev Respir Dis 136: 770-772, 1987.
37. Albelda SM, Smith CW and Ward PA, Adhesion molecules and inflammatory injury. FASEB J 8: 504-512, 1994.
38. Kaiser J, Bickel CA, Bochner BS and Schleimer RP, The effects of the potent glucocorticoid budesonide on adhesion of eosinophils to human endothelial cells and on endothelial expression of adhesion molecules. J Pharmacol Exp Ther 267: 245-249, 1993.
39. Knight SA, Smith CV and Welty SE, Iron and oxidized β-casein in the lavages of Fischer-344 rats. Life Sci 62: 165-176, 1998.
40. Yang C-Y, Gu Z-W, Yang H-X, Yang M, Wiseman WS, Rogers LK, Welty SE, Katta V, Rohde MF and Smith CV, Oxidation of bovine β-casein by hypochlorite. Free Radio Biol Med 22: 1235-1240, 1997.
41. Bradley PP, Christensen RD and Rothstein G, Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood 60: 618-622, 1982.